Atlas Trials

A Study to Explore Pharmacokinetics/Pharmacodynamics and Safety of Tegoprazan BID Dosing in Healthy Subjects

Clinical trial NCT04587011 · UNKNOWN

Trial details

NCT number
NCT04587011
Sponsor
HK inno.N Corporation
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2020-09-24
Primary completion
2021-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.